Flint Laura
Royal Infirmary of Edinburgh.
Nurs Times. 2004;100(12):34-7.
The first angiotensin-converting enzyme (ACE) inhibitors were introduced in 1981. They are used in the management of a variety of cardiovascular disorders and their role in hypertension, heart failure, managing asymptomatic and symptomatic left-ventricular dysfunction, post-myocardial infarction, stroke prevention, and diabetes is now well established. This is recognised in the National Service Framework for Coronary Heart Disease (Department of Health, 2000) and the guidelines from the British Hypertension Society (Ramsay et al, 1999). Nurses have a responsibility as part of the multidisciplinary team to have knowledge of various aspects of these drugs.
首批血管紧张素转换酶(ACE)抑制剂于1981年问世。它们用于多种心血管疾病的治疗,其在高血压、心力衰竭、无症状和有症状左心室功能障碍的管理、心肌梗死后、预防中风及糖尿病方面的作用现已得到充分确立。这一点在《冠心病国家服务框架》(卫生部,2000年)及英国高血压学会的指南(拉姆齐等人,1999年)中均有体现。作为多学科团队的一员,护士有责任了解这些药物的各个方面。